Global Vaccine Pipeline Database 2017 by Company, Indication & Clinical Trial Phase
Dublin, Nov. 27, 2017 (GLOBE NEWSWIRE) -- The "Vaccine Pipeline Database - 2017 Update" report has been added to Research and Markets' offering.
Vaccines Pipeline Highlights Database - 2017 Update, provides most up-to-date information on key pipeline products in the global Vaccines market. It covers emerging vaccine for diseases in active clinical development stages including early and late stage clinical trials. The pipeline data is presented in an excel dashboard with filtering options.
The pipeline data presented in this database helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.
By Indication:
The database presents vaccine pipeline by indications.
By Clinical Trial Stages:
The database provides Vaccines pipeline by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.
By Company:
The database provides Vaccines pipeline products by the company.
Summary:
- Vaccines Pipeline by Indication
- Vaccines Pipeline by Clinical Trial Phase
- Vaccines Pipeline by Company
For more information about this report visit https://www.researchandmarkets.com/research/r38sgf/vaccine_pipeline
CONTACT: Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Vaccines
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
